Geberit AG (GEBN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 27 Oct 2026
Key indicators
| Last close | CHF 576.60 |
|---|---|
| 52-week range | 490.40 – 659.80 |
| Return, 1 month / 3 months | +5.6% / +11.4% |
| Return, 1 year / 3 years | −2.8% / +47.3% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 22.2% |
| Worst drawdown (1 year) | -22.7% |
| Average daily value traded | 37.60M CHF |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Geberit AG is a Swiss manufacturer of sanitary technology and plumbing products. The company makes concealed cisterns, flushing systems, pipework and drainage products, taps, and bathroom ceramics, along with the fittings that connect them. Its customers are mainly plumbing and heating installers, sanitary engineers, and the construction and renovation trade, who fit these systems into homes and commercial buildings. Geberit is based in Switzerland and supplies its products across European and other international markets through distributors and trade channels.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code GEBN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Geberit AG (GEBN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 576.60 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 72 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.8% and over the last three months it rose 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -11.9% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.4% | ||
| 6-month return | 7.7% | ||
| 12-month return, skipping the last month | -8.0% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.7% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 37.60M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | +5.6% |
| 3 months | +11.4% |
| 6 months | +7.7% |
| 1 year | −2.8% |
| 3 years | +47.3% |
| 5 years | −9.1% |
Signals
| 50-day / 200-day average | 553.63 / 548.10 |
|---|---|
| Golden / death cross (60 days) | Golden, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | CHF 12.9000 |
| 22 Apr 2025 | CHF 12.8000 |
| 19 Apr 2024 | CHF 12.7000 |
| 21 Apr 2023 | CHF 12.6000 |
| 19 Apr 2022 | CHF 12.5000 |
| 16 Apr 2021 | CHF 11.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.